{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:32:36Z","timestamp":1784665956615,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control & Prevention","doi-asserted-by":"publisher","award":["2016-ER6304-02"],"award-info":[{"award-number":["2016-ER6304-02"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s40256-019-00326-8","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T23:37:17Z","timestamp":1550619437000},"page":"403-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9669-3598","authenticated-orcid":false,"given":"Yong Hoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ae-Young","family":"Her","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Jin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Guk","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong-Ki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangsoo","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"issue":"4","key":"326_CR1","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742cf6","volume":"127","author":"PT O\u2019Gara","year":"2013","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW. American College of Cardiology Foundation\/American Heart Association Task Force on Practice guidelines. Circulation. 2013;127(4):e362\u2013425. \n                    https:\/\/doi.org\/10.1161\/CIR.0b013e3182742cf6\n                    \n                  .","journal-title":"Circulation."},{"issue":"25","key":"326_CR2","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/CIR.0000000000000134","volume":"130","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ, ACC\/AHA Task Force Members. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):e344\u2013426. \n                    https:\/\/doi.org\/10.1161\/CIR.0000000000000134\n                    \n                  .","journal-title":"Circulation."},{"issue":"24","key":"326_CR3","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139\u2013228. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2014.09.017\n                    \n                  .","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"326_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsk\u00fd P, ESC Scientific Document Group. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehx393\n                    \n                  .","journal-title":"Eur Heart J."},{"issue":"9497","key":"326_CR5","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","volume":"366","author":"ZM Chen","year":"2005","unstructured":"Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, Xie JX, Liu LS, COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366(9497):1622\u201332. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(05)67661-1\n                    \n                  .","journal-title":"Lancet."},{"issue":"9266","key":"326_CR6","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","volume":"357","author":"HJ Dargie","year":"2001","unstructured":"Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357(9266):1385\u201390.","journal-title":"Lancet."},{"issue":"3","key":"326_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000129528","volume":"29","author":"D Libersan","year":"1997","unstructured":"Libersan D, Marchand R, Montplaisir S, Chartrand C, Dumont L. Cardioprotective effects of diltiazem during acute rejection on heterotopic heart transplants. Eur Surg Res. 1997;29(3):229\u201336. \n                    https:\/\/doi.org\/10.1159\/000129528\n                    \n                  .","journal-title":"Eur Surg Res."},{"issue":"5","key":"326_CR8","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1253\/circj.CJ-12-0963","volume":"77","author":"T Nishino","year":"2013","unstructured":"Nishino T, Furukawa Y, Kaji S, Ehara N, Shiomi H, Kim K, Kitai T, Kinoshita M, Morimoto T, Sakata R, Kimura T, CREDO-Kyoto PCI\/CABG Registry Cohort-2 Investigators. Distinct survival benefits of angiotensin-converting enzyme inhibitors\/angiotensin II receptor blockers in revascularized coronary artery disease patients according to history of myocardial infarction. Circ J. 2013;77(5):1242\u201352.","journal-title":"Circ J."},{"issue":"9215","key":"326_CR9","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","volume":"355","author":"MD Flather","year":"2000","unstructured":"Flather MD, Yusuf S, K\u00f8ber L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moy\u00e9 L, Braunwald E. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet. 2000;355(9215):1575\u201381.","journal-title":"Lancet."},{"key":"326_CR10","doi-asserted-by":"publisher","first-page":"g6650","DOI":"10.1136\/bmj.g6650","volume":"349","author":"JH Yang","year":"2014","unstructured":"Yang JH, Hahn JY, Song YB, Choi SH, Choi JH, Lee SH, Jeong MH, Choi DJ, Park JS, Park HS, Gwon HC. Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study. BMJ. 2014;349:g6650. \n                    https:\/\/doi.org\/10.1136\/bmj.g6650\n                    \n                  .","journal-title":"BMJ."},{"issue":"23","key":"326_CR11","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"CW Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Committee for Practice Guidelines. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):2999\u20133054. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehr236\n                    \n                  .","journal-title":"Eur Heart J."},{"issue":"20","key":"326_CR12","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Steg PG, James SK, Atar D, Badano LP, Bl\u00f6mstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van\u2019t Hof A, Widimsky P, Zahger D, Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569\u2013619. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehs215\n                    \n                  .","journal-title":"Eur Heart J."},{"issue":"16","key":"326_CR13","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC\/ACCF\/AHA\/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasch\u00e9 P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020\u201335. \n                    https:\/\/doi.org\/10.1161\/cir.0b013e31826e1058\n                    \n                  .","journal-title":"Circulation."},{"issue":"8498","key":"326_CR14","first-page":"57","volume":"2","author":"ISIS-1 (First International Study of Infarct Survival) Collaborative Group","year":"1986","unstructured":"ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1. Lancet. 1986;2(8498):57\u201366.","journal-title":"Lancet."},{"issue":"5","key":"326_CR15","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ahj.2011.01.006","volume":"161","author":"MC Kontos","year":"2011","unstructured":"Kontos MC, Diercks DB, Ho PM, Wang TY, Chen AY, Roe MT. Treatment and outcomes in patients with myocardial infarction treated with acute beta-blocker therapy: results from the American College of Cardiology\u2019s NCDR\u00ae. Am Heart J. 2011;161(5):864\u201370. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2011.01.006\n                    \n                  .","journal-title":"Am Heart J."},{"issue":"3","key":"326_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1017\/S1481803500010137","volume":"10","author":"A Al-Reesi","year":"2008","unstructured":"Al-Reesi A, Al-Zadjali N, Perry J, Fergusson D, Al-Shamsi M, Al-Thagafi M, Stiell I. Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis. CJEM. 2008;10(3):215\u201323.","journal-title":"CJEM."},{"issue":"12A","key":"326_CR17","doi-asserted-by":"publisher","first-page":"30H","DOI":"10.1016\/S0002-9149(03)00432-6","volume":"91","author":"SI McFarlane","year":"2003","unstructured":"McFarlane SI, Kumar A, Sowers JR. Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. Am J Cardiol. 2003;91(12A):30H\u20137H.","journal-title":"Am J Cardiol."},{"issue":"6","key":"326_CR18","doi-asserted-by":"publisher","first-page":"e0198144","DOI":"10.1371\/journal.pone.0198144","volume":"13","author":"J Ramchand","year":"2018","unstructured":"Ramchand J, Patel SK, Srivastava PM, Farouque O, Burrell LM. Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS One. 2018;13(6):e0198144. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0198144\n                    \n                  .","journal-title":"PLoS One."},{"issue":"9200","key":"326_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","volume":"355","author":"Heart Outcomes Prevention Evaluation (HOPE) Study Investigators","year":"2000","unstructured":"Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355(9200):253\u20139.","journal-title":"Lancet."},{"issue":"8875","key":"326_CR20","first-page":"821","volume":"342","author":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","year":"1993","unstructured":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342(8875):821\u20138.","journal-title":"Lancet."},{"issue":"8","key":"326_CR21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/CIRCULATIONAHA.105.594986","volume":"114","author":"MH Strauss","year":"2006","unstructured":"Strauss MH, Hall AS. Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox. Circulation. 2006;114(8):838\u201354. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.594986\n                    \n                  .","journal-title":"Circulation."},{"key":"326_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2014.03.055","volume":"114","author":"M Hara","year":"2014","unstructured":"Hara M, Sakata Y, Nakatani D, Suna S, Usami M, Matsumoto S, Sugitani T, Nishino M, Sato H, Kitamura T, Nanto S, Hamasaki T, Hori M, Komuro I. Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker. Am J Cardiol. 2014;114:1\u20138. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2014.03.055\n                    \n                  .","journal-title":"Am J Cardiol."},{"key":"326_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40256-015-0140-5","volume":"15","author":"PS Song","year":"2015","unstructured":"Song PS, Seol SH, Seo GW, Kim DK, Kim KH, Yang JH, Hahn JY, Gwon HC, Ahn Y, Jeong MH, Song YB, Kim DI, Other Korean Working Group in Myocardial Infarction Registry Investigators. Comparative effectiveness of angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors following contemporary treatments in patients with acute myocardial infarction: results from the Korean Working Group in Myocardial Infarction (KorMI) Registry. Am J Cardiovasc Drugs. 2015;15:439\u201349. \n                    https:\/\/doi.org\/10.1007\/s40256-015-0140-5\n                    \n                  .","journal-title":"Am J Cardiovasc Drugs."},{"issue":"4","key":"326_CR24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jacc.2005.09.055","volume":"47","author":"J McMurray","year":"2006","unstructured":"McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, K\u00f8ber L, Van de Werf F, Califf R, Pfeffer M. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). J Am Coll Cardiol. 2006;47(4):726\u201333. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2005.09.055\n                    \n                  .","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"326_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jjcc.2016.03.012","volume":"69","author":"H Park","year":"2017","unstructured":"Park H, Kim HK, Jeong MH, Cho JY, Lee KH, Sim DS, Yoon NS, Yoon HJ, Hong YJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kim YJ, Cho MC, Kim CJ, Korea Acute Myocardial Infarction Registry Investigators. Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention. J Cardiol. 2017;69(1):216\u201321. \n                    https:\/\/doi.org\/10.1016\/j.jjcc.2016.03.012\n                    \n                  .","journal-title":"J Cardiol."},{"issue":"8","key":"326_CR26","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1253\/circj.CJ-10-1241","volume":"75","author":"M Konishi","year":"2011","unstructured":"Konishi M, Haraguchi G, Yoshikawa S, Kimura S, Inagaki H, Isobe M. Additive effects of beta-blockers on renin-angiotensin system inhibitors for patients after acute myocardial infarction treated with primary coronary revascularization. Circ J. 2011;75(8):1982\u201391.","journal-title":"Circ J."},{"issue":"1","key":"326_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0002-9149(77)90108-4","volume":"40","author":"A Zweifler","year":"1977","unstructured":"Zweifler A, Esler M. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension. Am J Cardiol. 1977;40(1):105\u20139.","journal-title":"Am J Cardiol."},{"issue":"10","key":"326_CR28","doi-asserted-by":"publisher","first-page":"e2971","DOI":"10.1097\/MD.0000000000002971","volume":"95","author":"PH Lee","year":"2016","unstructured":"Lee PH, Park GM, Kim YH, Yun SC, Chang M, Roh JH, Yoon SH, Ahn JM, Park DW, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ. Effect of beta blockers and renin-angiotensin system inhibitors on survival in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Medicine. 2016;95(10):e2971. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000002971\n                    \n                  .","journal-title":"Medicine."},{"issue":"2","key":"326_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jacc.2012.10.011","volume":"61","author":"G Savarese","year":"2013","unstructured":"Savarese G, Costanzo P, Cleland JG, Vassallo E, Ruggiero D, Rosano G, Perrone-Filardi P. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure. J Am Coll Cardiol. 2013;61(2):131\u201342. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2012.10.011\n                    \n                  .","journal-title":"J Am Coll Cardiol."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-019-00326-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-019-00326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-019-00326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T19:14:42Z","timestamp":1582139682000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-019-00326-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1007\/s40256-019-00326-8","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,20]]},"assertion":[{"value":"20 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This research was supported by research funding (2016-ER6304-02) from the Korea Centers for Disease Control and Prevention.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Yong Hoon Kim, Ae-Young Her, Myung Ho Jeong, Byeong-Keuk Kim, Sung-Jin Hong, Dong-Ho Shin, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, and Yangsoo Jang have no conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}